Clinical Trial Information
Principal Investigator: Ali Naji, MD
Title: B-Lymphocyte Immunotherapy in Islet Transplantation: Toward Calcineurin Inhibitor Free Immunosuppression
Sponsor: National Institutes of Health
Objective: To establish the efficacy of a novel immunosuppression approach in islet transplantation as a treatment for type 1 diabetes complicated by severe hypoglycemia.
Eligibility: The study is closed to new enrollment. Participants are currently in follow-up.
Eileen Markmann, BSN, RN
Cornelia V. Bakes (Ginger)